Effects of insulin therapy and glycemic control on distribution of HDL α and pre-β subfractions in non insulin-dependent diabetic subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 1, 1999, Pages 19-24

  Sasahara, T ^a   Jerums, G ^a   Nestel, P ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

HDL subfractions; Insulin therapy; Non insulin dependent diabetes

Indexed keywords

ANTIDIABETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DIET THERAPY; DRUG EFFECT; ELECTROPHORESIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOBLOTTING; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIET THERAPY; ELECTROPHORESIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOBLOTTING; INSULIN; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0033068763     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wilson PWF, Kannel WB (1992) Epidemiology of hyperglycemia and atherosclerosis. In: Ruderman N, Williamson J, Brownlee M (eds), Hyperglycemia, diabetes, and vascular disease. New York, NY, Oxford University Press; 2: 21-29
2. Garg A, Grundy SM (1990) Management of dyslipidemia in NIDDM. Diabetes Care 13: 153-169
3. Bierman EL (1992) Atherogenesis in diabetes. Arterioscler Thromb 12: 647-656
4. Rainwater DL, Mitchell BD, Mahaney MC, Haffner SM (1997) Genetic relationship between measures of HDL phenotypes and insulin concentrations. Arterioscler Thromb Vase Biol 17: 3414-3419.
5. Calvert GD, Graham JJ, Mannik T, Wise PH, Yeates RA (1978) Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet 1: 66-68
6. Laakso M, Sarlund H, Mykkänen (1990) Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arterioscler Thromb 10: 223-231
7. Tilly-Kiesi M, Knudsen P, Groop L, Taskinen M-R and the Botnia Study Group (1996) Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. J Lipid Res 37: 1569-1578
8. 2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics. Metabolism 34: 715-716
9. Taskinen MR (1990) Hyperlipidemia in diabetes. Ballieres Clin Endocrinol Metab 4: 743-775
10. Barter PJ, Rye K-A (1996) High density lipoproteins and coronary heart disease. Atherosclerosis 121: 1-12
11. Abate N, Vega GL, Garg A, Grundy SM (1995) Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis 118: 111-122
12. Sasahara Y, Yamashita T, Sviridov D, Fidge N, Nestel PJ (1997) Altered properties of high density lipoprotein subtractions in obese subjects. J Lipid Res 38: 600-611
13. Huang Y, von Eckardstein A, Assman G (1993) Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 13: 445-458
14. Asztalos BF, Lefevre M, Foster TA, Tulley R, Windhauser M, Wong L, Roheim PS (1997) Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler Thromb Vase Biol 17: 885-1893
15. Cheung MC, Brown BG, Wolf AC, Albers JJ (1991) Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32: 383-394
16. Asztalos BF, Sloop CH, Wong L, Roheim PS (1993) Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations. Biochim Biophys Acta 1169: 291-300
17. Sviridov D, Fidge N (1995) Pathway of cholesterol efflux from human hepatoma cells. Biochim Biophys Acta 1256: 210-220
18. Cheung MC, Albers JJ (1984) Characterization of lipoprotein particles isolated by immunoaffinity. J Biol Chem 259: 12201-12209
19. Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC (1987) Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis 68: 35-40
20. Taylor KG, Wright AD, Carter TJN, Valente AJ, Betts SA, Matthews KA (1981) High density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non insulin-dependent diabetes. Diabetologia 20: 535-539
21. Taskinen MR, Beltz WF, Harper I (1986) Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy. Diabetes 35: 1268-1277